News
- Titlee2v wins £4m contract from TomoTherapy
- Date08 February 2006
US-based TomoTherapy® Incorporated has awarded a £4m (US$7m) contract to e2v technologies. The contract comprises a number of e2v compact modulators and magnetrons, which are used in TomoTherapy’s progressive Hi-Art® radiation therapy System. The e2v components will broaden TomoTherapy’s patient reach, enabling them to provide radiotherapy treatment to more cancer patients than is possible today.
The e2v system generates the prime energy for the Hi-Art’s accelerator, which delivers the X-rays used in the imaging and treatment of tumours. e2v’s compact, solid-state modulator is a high voltage, direct switching unit that has been designed for use in linear accelerators. Combined with a magnetron, electro-magnet and a microwave launching section, e2v supplies complete RF power systems to TomoTherapy® that are capable of delivering the required 3MW of peak microwave power to their Hi-Art System®.
The new order is part of long-term relationship between e2v and TomoTherapy® and represents significant growth in the annual quantity of systems provided. e2v will deliver the systems over the coming year. TomoTherapy® systems currently treat 500 cancer patients per day from 50 ‘clinical’ sites. The new systems will expand their existing capability, enabling even more patients to receive image-guided, intensity-modulated radiotherapy than is possible today.
Please note: Information on this contract was released on RNS announcement # 9950X.